| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 17,378 | 19,371 | 20,920 | 26,854 | | Cost of Revenue | 5,583 | 5,533 | 5,801 | 9,437 | | | Gross Profit | 11,795 | 13,838 | 15,119 | 17,417 | | | Operating Expenses | | Research Development | 503 | 582 | 515 | 497 | | Selling General and Administrative | 11,505 | 12,163 | 13,387 | 23,847 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (213) | 1,093 | 1,217 | (6,927) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,316 | 1,569 | 1,564 | 1,250 | | Earnings Before Interest And Taxes | 1,103 | 2,662 | 2,781 | (5,677) | | Interest Expense | 3 | 3 | 3 | 3 | | Income Before Tax | 1,100 | 2,659 | 2,778 | (5,680) | | Income Tax Expense | 382 | (5,875) | 1,226 | 4,449 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 718 | 8,534 | 1,552 | (10,129) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 718 | 8,534 | 1,552 | (10,129) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $718 | $8,534 | $1,552 | ($10,129) |
|
0.51% Nasdaq 
Income Statement
